|View printer-friendly version|
Spring Bank Strengthens Management Team to Enhance Operations
“The addition of Kevin, with extensive experience in the biopharmaceutical industry, significantly strengthens our management team,” said
Dr. Leach brings to the company over 13 years of experience in the biopharmaceutical industry. Prior to joining Spring Bank, he was senior director, nonclinical and translational research, at Retrophin, Inc., in Cambridge, MA. Before
In conjunction with Dr. Leach’s appointment,
Mr. Winslow, who has served as vice president, legal at Spring Bank since Jan. 2017, will continue to be responsible for corporate legal operations and function as the corporate secretary for Spring Bank. Prior to joining Spring Bank, Mr. Winslow served as a member in the corporate and securities group at Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. in Boston, where he advised public and private companies on securities law compliance, corporate governance matters and mergers and acquisitions. Mr. Winslow received his master's degree in taxation law from Boston University Law School, J.D. degree from Suffolk University Law School and B.A. degree in business administration from the University of Washington.
About Spring Bank Pharmaceuticals
For investor inquires:
LifeSci Advisors, LLC
Source: Spring Bank Pharmaceuticals, Inc.